![Kevin J. Fowler Principal The Voice of the Patient Profile](https://pbs.twimg.com/profile_images/1641456541659176962/TdXeXo4I_x96.jpg)
Kevin J. Fowler Principal The Voice of the Patient
@gratefull080504
Followers
5K
Following
35K
Statuses
26K
Consulting business: recruiting early intervention kidney disease + kidney transplant trials;Moved from Chicago back home to STL; Move treatment of CKD upstream
Saint Louis, MO
Joined January 2010
If there was ever an argument why the treatment of #kidneydisease must move upstream, look at 5 year survival on #hemodialysis + how it compares to cancer + other diseases Thanks @Kidney_Kula + @4_kidney for sharing cc @soledadobrien @PostRowland @KHNews @LizSzabo @NYTHealth
Reading the most recent issue of @CJASN and I was struck by this figure from Joseph Bonventreās editorial. I hope findings like these can help our health system appreciate the need for and value of nephrologists and their research! #medtwitter #pedneph
8
29
78
The FDA has provided approval to @UnitedTherapy21 to initiate #xenotransplantation in human mid-year 2025
United Therapeutics receives FDA clearance to begin a UKidneyā¢ #xenotransplantation trial for #ESRD patients ineligible for traditional transplants. The first transplant is expected mid-2025. Learn more: #KidneyTransplant #HealthcareInnovation
0
2
8
@Ask_Renal with the recent approval of Ozempic for DKD, what is the lowest GFR that the label permits to use Ozempic?
0
0
0
While this is exciting news, will this innovation reach the people that really need access to the treatment? Will this treatment reduce the fact that 33% of people on dialysis are African- American? #nephjc
0
0
0
The approval of the MediBeacon Inc.of the TGfR is a big first step in the advancement of #kidney health. eGFR is an insensitive biomarker that many times does not provide an accurate assessment of kidney function. This has implications in being placed on dialysis prematurely, eligibility to participate in a clinical trial, initiation of a nephroprotective treatment, etc. The MediBeacon Inc. device provides an improved assessment of kidney function.
FDA approves Transdermal GFR System (TGFR). See TGFR Sensor, TGFR Monitor, and LumitraceĀ®(relmapirazin) injection together allow kidney function assessment by measuring clearance rate of fluorescent agent as it leaves body. See
0
0
1
This a major step forward in advancing #kidneyhealth For full disclosure I am a consultant for @medibeacon
FDA approves Transdermal GFR System (TGFR). See TGFR Sensor, TGFR Monitor, and LumitraceĀ®(relmapirazin) injection together allow kidney function assessment by measuring clearance rate of fluorescent agent as it leaves body. See
0
2
11
@worldkidneyday @DaVita @worldkidneyday : What is Davita doing to detect + intervene early for kidney diseases?
0
0
0
@LorrindaD @hepatitisihelpc @LiverWife @4_kidney @kidneyrunner @HRSAgov @LorrindaD : where can I learn additional information so that I can make informed comments besides your recommendations?
2
0
0
@valerie_luyckx @bmiloj @sridhartweet @kramer_holly Happy to speak with you CKD Warrior. There are other avenues for kidney disease detection.
1
0
1
@QuestDX You lost my DSA test results and I want to file a complaint against your organization. What is the process to do so?
0
0
0